Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank.

Zhang, Xing-Yu; He, Qiang-Sheng; Jing, Zhong; He, Juan-Xia; Yuan, Jin-Qiu; Dai, Xiao-Yu

Zhang, Xing-Yu; He, Qiang-Sheng; Jing, Zhong; He, Juan-Xia; Yuan, Jin-Qiu; Dai, Xiao-Yu.

Afiliação

Zhang XY; Department of Nephrology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
He QS; Clinical Research Center, Guangdong; Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Jing Z; Department of Nephrology, Mianyang 404 Hospital, Mianyang, China.
He JX; Department of Information Engineering, University of Lanzhou City, Lanzhou, China.
Yuan JQ; Clinical Research Center, Guangdong; Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Dai XY; Department of Nephrology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Front Pharmacol ; 13: 949699, 2022.

Article em En | MEDLINE | ID: mdl-36438798

Palavras-chave

United Kingdom Biobank; chronic kidney disease; cohort; propensity score weighting via overlap weights; proton pump inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google